6 results on '"asthma epidemiology"'
Search Results
2. High BMI is related to higher incidence of asthma, while a fish and fruit diet is related to a lower–: Results from a long-term follow-up study of three age groups in Sweden.
- Author
-
Uddenfeldt, Monica, Janson, Christer, Lampa, Erik, Leander, Mai, Norbäck, Dan, Larsson, Lars, and Rask-Andersen, Anna
- Abstract
Summary: The causes of the worldwide increase in asthma seen during the last decades remain largely unexplained, but lifestyle and diet are suggested to play important roles. In this follow up of a large-scale population sample in Sweden, we wanted to identify modifiable risk factors for the cumulative incidence over a 13-year follow-up period. In 1990, a self-administered questionnaire was completed by 12,560 individuals from three age groups (16, 30–39 and 60–69 years of age) in two counties of Sweden. In 2003, the eligible subjects (n = 11,282) were sent a new postal questionnaire. In total 8150 (response rate 73%) answered the questionnaire. The prevalence of asthma in 2003 had increased in all ages. In the young adults, the asthma prevalence rose from 11.3% in 1990 to 25.0% in 2003. Adult asthma onset was identified in 791 of the participants. Smoking [RR (95% CI) = 1.37 (1.12–1.68)], BMI [1.49 (1.25–1.77 per inter quartile range)], and nocturnal gastro-oesophageal reflux (GOR) [2.16 (1.72–2.72)] were significant independent risk factors for the cumulative incidence of asthma. The impact of risk factors differed between the age groups where BMI and GOR had a significantly higher impact in the middle aged and the elderly (p < 0.05). High consumption of fruit and fish was protective especially in the elderly [0.52 (0.35–0.77)]. No significant difference was found in the impact of risk factors between men and women. Weight loss, smoking cessation and a diet rich in fruit and fish may be of importance in preventing onset of adult asthma. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
3. Central obesity is associated with nonatopic but not atopic asthma in a representative population sample.
- Author
-
Appleton, Sarah L., Adams, Robert J., Wilson, David H., Taylor, Anne W., and Ruffin, Richard E.
- Subjects
OBSTRUCTIVE lung diseases ,ASTHMA ,NUTRITION disorders ,PUBLIC health - Abstract
Background: Epidemiologic studies have consistently demonstrated the association between high body mass index (BMI) and asthma, yet the relationship between asthma and the alternative central obesity phenotypes, waist circumference (WC) and waist-to-hip ratio (WHR), has not been assessed in a representative population sample. Objective: To determine the strength of the association of WC and WHR with current asthma and whether the association is modified by atopic status in a representative population sample. Methods: The North West Adelaide Health Study, a biomedical population study of n = 4060, assessed current asthma, respiratory symptoms, and participant demographics by self-completed questionnaire. Clinic assessment included measures of WC and WHR, spirometry, and skin prick tests to a panel of allergens. Results: Logistic regression analysis showed a significant, marginal increased adjusted risk of asthma associated with obese levels of WC and WHR and BMI ≥35.0 kg/m
2 in female subjects only. When the association was considered stratified according to atopic status, the relationship between obese levels of WC and WHR with asthma held only for the nonatopic population in both males (WC: odds ratio [OR] 5.7, 95% confidence interval [CI] 1.1-28.8; WHR: OR 6.2, 95% CI, 1.1-32.9) and females (WC: OR 2.3, 95% CI, 1.2-4.4; WHR: OR 3.0, 95% CI, 1.5-5.9). BMI ≥35.0 kg/m2 showed an inconsistent pattern in the association with asthma. Conclusion: Central obesity was significantly associated with an increased risk of nonatopic asthma only. The causal pathway is unknown, but this study suggests the involvement of different pathophysiological mechanisms requiring further investigation. Clinical implications: Asthma should be considered in older, nonatopic, centrally obese, symptomatic individuals. [Copyright &y& Elsevier]- Published
- 2006
- Full Text
- View/download PDF
4. Is the Incidence of Near-Fatal Asthma Decreasing in Spain?
- Author
-
Casado, Jesús Bellido, Plaza, Vicente, Bardagí, Santiago, Cosano, Javier, Viña, Antolín Ló;pez, Moragón, Eva Martínez, Rodríguez-Trigo, Gema, Picado, César, and Sanchis, Joaquim
- Subjects
ASTHMA ,MORTALITY ,HOSPITAL care ,HOSPITALS - Abstract
Copyright of Archivos de Bronconeumología (English Edition) is the property of Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
- Full Text
- View/download PDF
5. Spirometric criteria for asthma: Adding further evidence to the debate.
- Author
-
Appleton, Sarah L., Adams, Robert J., Wilson, David H., Taylor, Anne W., and Ruffin, Richard E.
- Subjects
ASTHMA ,PUBLIC health ,BRONCHODILATOR agents ,MEDICAL literature - Abstract
Background: Objective assessments of pulmonary function are considered essential for the diagnosis of asthma. The degree of reversibility of FEV
1 considered supportive of asthma varies between international asthma guidelines. Objective: We sought to compare the relative performance of international guideline reversibility criteria for identifying impairment in persons with a significant bronchodilator response (SBR) without an asthma diagnosis. Methods: The North West Adelaide Health (Cohort) Study, a population biomedical study of 4060 subjects, conducted spirometry according to American Thoracic Society criteria. SBR was defined as postbronchodilator FEV1 responses of at least 12% or 15% of baseline values, 9% of predicted values, or 400 mL. A self-completed questionnaire assessed current asthma (CA), respiratory symptoms, and participant demographics. Results: The prevalence of CA was 9.4% (n = 380), whereas 1.3% (≥400 mL) to 4.5% (≥9% of predicted value) of participants demonstrated an SBR in the absence of CA. With the exception of the 9% predicted criterion, prebronchodilator mean FEV1 (percent predicted) in those demonstrating an SBR but no CA was significantly worse than that in the CA group. Significantly more respiratory symptoms were experienced by the SBR groups than the group without asthma. Logistic regression analyses identified different characteristics of those classified by the following criteria: 12% and 15%, age of 40 years or greater and household income of less than $40,000; 9% predicted, household income of less than $40,000; 400 mL, male sex (odds ratio, 4.5; 95% CI, 2.1-9.3). Conclusions: Different criteria identify different persons, but SBR by any criteria was associated with significant respiratory impairment, some of which might be attributable to asthma. Postbronchodilator change as a percentage of predicted value was the least biased of the criteria. [Copyright &y& Elsevier]- Published
- 2005
- Full Text
- View/download PDF
6. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies.
- Author
-
SAUL, PETER, Chalitsios, Christos V, Shaw, Dominick E, and McKeever, Tricia M
- Subjects
ASTHMA ,OSTEOPOROSIS - Abstract
Background: Inhaled (ICS) and oral (OCS) corticosteroids are used widely in asthma; however, the risk of osteoporosis and fragility fracture (FF) due to corticosteroids in asthma is not well-established.Methods: We conducted two nested case-control studies using linked data from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES) databases. Using an asthma cohort, we separately identified patients with osteoporosis or FF and gender-, age- and practice-matched controls. Conditional logistic regression was used to determine the association between ICS and OCS exposure, and the risk of osteoporosis or FF. The prevalence of patients receiving at least one bisphosphonate was also calculated.Results: There was a dose-response relationship between both cumulative dose and number of OCS/ICS prescriptions within the previous year, and risk of osteoporosis or FF. After adjusting for confounders, people receiving more OCS prescriptions (≥9 vs 0) had a 4.50 (95% CI 3.21 to 6.11) and 2.16 (95% CI 1.56 to 3.32) increased risk of osteoporosis and FF, respectively. For ICS (≥11 vs 0) the ORs were 1.60 (95% CI 1.22 to 2.10) and 1.31 (95% CI 1.02 to 1.68). The cumulative dose had a similar impact, with those receiving more OCS or ICS being at greater risk. The prevalence of patients taking ≥9 OCS and at least one bisphosphonate prescription was just 50.6% and 48.4% for osteoporosis and FF, respectively.Conclusions: The findings suggest that exposure to OCS or ICS is an independent risk factors for bone health in patients with asthma. Steroid administration at the lowest possible level to maintain asthma control is recommended. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.